Charles V. Baltic III, Director at MEI Pharma, Inc. (MEIP), bought 11,000 shares at $2.25 ($25K) on 2017-11-27, disclosed to the SEC on 2017-11-29.
Open-market purchase of $25k MEIP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| MEIP | BUY | 2015-01-02 | $13K | — | Filing → |
| MEIP | BUY | 2014-07-02 | $13K | — | Filing → |
| MEIP | BUY | 2013-08-20 | $18K | — | Filing → |